By Kathy Lee-Sepsick

For decades, women’s health, especially reproductive care, has been underserved by medical innovation. Invasive and expensive procedures, limited options, and outdated approaches have been the norm. But that’s changing rapidly. The rise of Femtech -- a field projected to grow from $7.75 billion in 2024 to $29.62 billion by 2032 -- is revolutionizing healthcare by addressing the unique and evolving needs of women, including specific conditions such as infertility, contraception, maternal and menstrual health, pelvic and sexual health, and menopause. Femtech is the industry segment creating new pathways for women to take control of their specific well-being.

Breaking barriers in women's health
Progress in women’s health has historically lagged, with many treatments remaining largely unchanged for decades. However, recent innovations are beginning to transform this landscape, offering renewed hope to millions. Consider fertility care -- approximately 1 in 6 American couples experience infertility, with female and male infertility factors contributing equally. Additionally, around 10% of women in the U.S. have difficulty getting pregnant or staying pregnant.

On the other end of the spectrum, nearly half of all pregnancies in the U.S. are unintended. This highlights the urgent need for more accessible, effective, and affordable solutions for both conception and contraception. These are needs that Femtech is uniquely positioned to address.

Femtech start-ups are addressing long-standing gaps in women’s healthcare by developing modern medical technologies and services that prioritize convenience, affordability, and less invasive care. Despite this progress, innovation in the field remains challenging. Founders face regulatory barriers, constrained funding, limited research on women’s health, and a historical lack of prioritization within the healthcare industry. These issues are compounded by the complexity of navigating a fragmented healthcare system, often slowing advancement. Even so, rising demand for targeted solutions is driving continued development of improved, evidence-based technologies designed to better serve women’s health needs.

Revolutionizing reproductive health: The rise of minimally invasive solutions
Minimally invasive technologies are among the most exciting developments within Femtech. For example, new fertility treatments offer alternatives to traditional in-vitro fertilization (IVF). The latest fertility treatment, known as intratubal insemination (ITI), provides better conception success rates than traditional intrauterine insemination while offering patients a less expensive and less invasive alternative to conventional IVF

Business Affairs Homepage